BioSpace News Archive

The Leapfrog Group, an independent national health care watchdog organization, released Safety In Numbers: Hospital Performance on Leapfrog’s Surgical Volume Standard Based on Results of the 2019 Leapfrog Hospital Survey.

BrainStorm Cell Therapeutics Inc. announced that Partners MS Center at Brigham and Women’s Hospital, a leading research and clinical care center, has contracted with BrainStorm as a clinical study site for the Company’s Phase 2 open-label, multicenter study of repeated intrathecal administration of NurOwn® in participants with progressive Multiple Sclerosis.

Builds on Hikma’s leading position in nasal sprays and strong specialty salesforce

Sedana Medical AB announced that the company is donating the medical device AnaConDa and accessories for anti-epidemic use and evaluation of the effects of inhalation sedation with AnaConDa on severely ill Corona virus affected patients to two hospitals in Wuhan and Zhejiang, China.

Dr. Reddy’s Laboratories Ltd. announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® Delayed-Release Tablets approved by the U.S. Food and Drug Administration.